The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Aspirin has been observed to reduce the risk of developing hepatocellular carcinoma (HCC). This review pooled together the results of all available published studies and found that aspirin reduces the risk of HCC by around 30%. In patients with cirrhosis, this effect was not seen and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelmalak, Jonathan, Tan, Natassia, Con, Danny, Eslick, Guy, Majeed, Ammar, Kemp, William, Roberts, Stuart K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341252/
https://www.ncbi.nlm.nih.gov/pubmed/37444628
http://dx.doi.org/10.3390/cancers15133518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341252/
https://www.ncbi.nlm.nih.gov/pubmed/37444628
http://dx.doi.org/10.3390/cancers15133518

Ejemplares similares